198 related articles for article (PubMed ID: 31738404)
21. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
22. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
24. Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer.
Fujii T; Shimada K; Tatsumi Y; Tanaka N; Fujimoto K; Konishi N
Mol Carcinog; 2016 Sep; 55(9):1378-86. PubMed ID: 26259043
[TBL] [Abstract][Full Text] [Related]
25. miR-210 is induced by hypoxia and regulates neural cell adhesion molecule in prostate cells.
Angel CZ; Lynch SM; Nesbitt H; McKenna MM; Walsh CP; McKenna DJ
J Cell Physiol; 2020 Sep; 235(9):6194-6203. PubMed ID: 31975433
[TBL] [Abstract][Full Text] [Related]
26. MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.
Du Y; Liu XH; Zhu HC; Wang L; Ning JZ; Xiao CC
Cell Physiol Biochem; 2017; 41(3):1135-1146. PubMed ID: 28245474
[TBL] [Abstract][Full Text] [Related]
27. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K
Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508
[TBL] [Abstract][Full Text] [Related]
28. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.
Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL
Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757
[TBL] [Abstract][Full Text] [Related]
29. Cadherin-11 promotes the metastasis of prostate cancer cells to bone.
Chu K; Cheng CJ; Ye X; Lee YC; Zurita AJ; Chen DT; Yu-Lee LY; Zhang S; Yeh ET; Hu MC; Logothetis CJ; Lin SH
Mol Cancer Res; 2008 Aug; 6(8):1259-67. PubMed ID: 18708358
[TBL] [Abstract][Full Text] [Related]
30. Roles of MicroRNA21 and MicroRNA29a in Regulating Cell Adhesion Related Genes in Bone Metastasis Secondary to Prostate Cancer.
Mohamad M; Wahab NA; Yunus R; Murad NA; Zainuddin ZM; Sundaram M; Mokhtar NM
Asian Pac J Cancer Prev; 2016; 17(7):3437-45. PubMed ID: 27509989
[TBL] [Abstract][Full Text] [Related]
31. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
[TBL] [Abstract][Full Text] [Related]
32. Osteoblast-like cells in human cancers: new cell type and reliable markers for bone metastasis.
Scimeca M; Bonfiglio R; Montanaro M; Bonanno E
Future Oncol; 2018 Jan; 14(1):9-11. PubMed ID: 29219614
[No Abstract] [Full Text] [Related]
33. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis.
Lee YC; Bilen MA; Yu G; Lin SC; Huang CF; Ortiz A; Cho H; Song JH; Satcher RL; Kuang J; Gallick GE; Yu-Lee LY; Huang W; Lin SH
Mol Cancer Res; 2013 Nov; 11(11):1401-11. PubMed ID: 23913163
[TBL] [Abstract][Full Text] [Related]
35. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
Wu CL; Ho JY; Chou SC; Yu DS
Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
[TBL] [Abstract][Full Text] [Related]
37. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.
Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X
Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922
[TBL] [Abstract][Full Text] [Related]
38. miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis.
Seashols-Williams SJ; Budd W; Clark GC; Wu Q; Daniel R; Dragoescu E; Zehner ZE
PLoS One; 2016; 11(7):e0159601. PubMed ID: 27447934
[TBL] [Abstract][Full Text] [Related]
39. Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model.
Banyard J; Chung I; Wilson AM; Vetter G; Le Béchec A; Bielenberg DR; Zetter BR
Sci Rep; 2013 Nov; 3():3151. PubMed ID: 24193225
[TBL] [Abstract][Full Text] [Related]
40. Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression.
Kolijn K; Verhoef EI; Smid M; Böttcher R; Jenster GW; Debets R; van Leenders GJLH
Cancer Res; 2018 Aug; 78(16):4671-4679. PubMed ID: 29921693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
